SRS Capital Advisors »

Nurix Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.9k 130 22.48
2024-06-30 $2.7k 130 20.88

More positions owned by SRS Capital Advisors

Vanguard Index Fds Value Etf (VTV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Schwab Strategic Tr Us Tips Etf (SCHP)
Vanguard Index Fds Growth Etf (VUG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Index Fds Mid Cap Etf (VO)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for SRS Capital Advisors

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Baker Bros. Advisors
T. Rowe Price Associates
T. Rowe Price Investment Management
ARK Investment Management
Pictet Asset Management Holding SA
Commodore Capital
Citadel Advisors
Geode Capital Management
Driehaus Capital Management
Affinity Asset Advisors
Deutsche Bank Aktiengesellschaft
Daniel D. Thurber
Samlyn Capital

View all funds holding Nurix Therapeutics